Weiming Xia, Ph.D.

Professor, Pharmacology and Experimental Therapeutics, Boston University School of Medicine

Dr. Weiming Xia received his bachelor of science degree from Fudan University, China and Ph.D. degree from the University of Texas Medical School at Houston, Texas, USA. He pursued postdoctoral training in Dr. Dennis Selkoe’s laboratory in 1995 and joined the faculty at the Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School in 1999. During 2009-2012, Dr. Xia devoted his effort to developing Alzheimer therapeutics in a start-up company before he returned to academia at Veteran Affairs Hospital and Boston University School of Medicine. Currently he is the acting Associate Director of Research at the Geriatric Research Education and Clinical Center at the Bedford VA Hospital. Dr. Xia has over 20 years of experience in target identification, characterization, validation and early stage drug development, with exploration of clinical biomarkers for Alzheimer’s disease. His lab has established a number of in vitro, cellular, and zebrafish-based high-content, whole-animal assays to characterize drug targets. Dr. Xia has published over 100 original research articles, reviews/book chapters and edited a book. His research, currently supported by NIH, the Department of Veteran Affairs, and Cure Alzheimer’s Fund, focuses on the molecular mechanisms responsible for pathological changes in AD, on biomarkers reflecting disease progression, and on exploration and discovery of therapeutic interventions.

Funded Research

These projects were made possible from Cure Alzheimer's Fund support.

Selected Publications

These published papers resulted from Cure Alzheimer’s Fund support.

Xia W. Gamma-Secretase and its modulators: Twenty years and beyond, Neuroscience Letters, February 11, 2019, Read More

Lee, H. K., Velazquez Sanchez, C., Chen, M., Morin, P. J., Wells, J. M., Hanlon, E. B., & Xia, W. Three dimensional human neuro-spherod model of Alzheimer’s disease based on differentiated induced pluripotent stem cells, PLoS One, September 29, 2016, Read More

Gaudiuso, R., Ewusi-Annan, E., Xia, W., & Melikechi, N. Diagnosis of Alzheimer’s disease using laser-induced breakdown spectroscopy and machine learning, Spectrochimica Acta Part B: Atomic Spectroscopy, July 15, 2020, Read More

Huttunen, H. J., Havas, D., Peach, C., Barren, C., Duller, S., Xia, W., Frosch, M. P., Hutter-Paier, B., Windisch, M., & Kovacs, D. M. The Acyl-coenzyme A: cholesterol Acyltransferase Inhibitor CI-1011 Reverses Diffuse Brain Amyloid pathology in aged amyloid precursor protein transgenic mice, Journal of Neuropathology & Experimental Neurology, August 1, 2010, Read More

Zhou, J., Shi, Q., Ge, Y. Y., He, W., Hu, X., Xia, W., & Yan, R. Reticulon 1 and 3 are essential for axonal growth and synaptic maintenance associated with the intellectual development, Human Molecular Genetics, May 25, 2023, Read More

Li, X., Wang, L., Cykowski, M., He, T., Liu, T., Chakranarayan, J., Rivera, A., Zhao, H., Powell, S., Xia, W., & Wong, S. T. C. OCIAD1 contributes to neurodegeneration in Alzheimer’s disease by inducing mitochondria dysfunction, neuronal vulnerability and synaptic damages, eBioMedicine, January 10, 2020, Read More

Kwak, S. S., Washicosky, K. J., Brand, E., von Maydell, D., Aronson, J., Kim, S., Capen, D. E., Cetinbas, M., Sadreyev, R., Ning, S., Bylykbashi, E., Xia, W., Wagner, S. L., Choi, S. H., Tanzi, R. E., & Kim, D. Y. Amyloid-β42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer’s disease, Nature Communications, March 13, 2020, Read More

Jun, G. R., You, Y., Zhu, C., Meng, G., Chung, J., Panitch, R., Hu, J., Xia, W., Alzheimer's Disease Genetics Consortium, Bennett, D. A., Foroud, T. M., Wang, L. S., Haines, J. L., Mayeux, R., Pericak-Vance, M. A., Schellenberg, G. D., Au, R., Lunetta, K. L., Ikezu, T., Stein, T. D., … Farrer, L. A. Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE ɛ2 for Alzheimer’s disease., Alzheimer's & Dementia, February 9, 2022, Read More

Muraoka, S., Lin, W., Chen, M., Hersh, S. W., Emili, A., Xia, W., & Ikezu, T. Assessment of separation methods for extracellular vesicles from human and mouse brain tissues and human cerebrospinal fluids, Methods, February 5, 2020, Read More

Muraoka, S., DeLeo, A. M., Sethi, M. K., Yukawa-Takamatsu, K., Yang, Z., Ko, J., Hogan, J. D., Ruan, Z., You, Y., Wang, Y., Medalla, M., Ikezu, S., Chen, M., Xia, W., Gorantla, S., Gendelman, H. E., Issadore, D., Zaia, J., & Ikezu, T. Proteomic and biological profiling of extracellular vesicles from Alzheimer’s disease human brain tissues, Alzheimer's & Dementia, April 17, 2020, Read More

Chen, M., Song, H., Cui, J., Johnson, C. E., Hubler, G. K., DePalma, R. G., Gu, Z., & Xia, W. Proteomic Profiling of Mouse Brains Exposed to Blast-Induced Mild Traumatic Brain Injury Reveals Changes in Axonal Proteins and Phosphorylated Tau, Journal of Alzheimer's Disease, October 30, 2018, Read More

Chen, M., & Xia, W. Proteomic Profiling of Plasma and Brain Tissue from Alzheimer’s Disease Patients Reveals Candidate Network of Plasma Biomarkers, Journal of Alzheimer's Disease, June 30, 2020, Read More

Konan, L. M., Song, H., Pentecost, G., Fogwe, D., Ndam, T., Cui, J., Johnson, C. E., Grant, D., White, T., Chen, M., Xia, W., Cernak, I., DePalma, R. G., & Gu, Z. Multi-Focal Neuronal Ultrastructural Abnormalities and Synaptic Alterations in Mice after Low-Intensity Blast Exposure, Journal of Neurotrauma, March 13, 2019, Read More

Chen, M., Lee, H. K., Moo, L., Hanlon, E., Stein, T., & Xia, W. Common Proteomic profiles of induced pluripotent stem cell-derived three-dimensional neurons and brain tissue from Alzheimer’s patients, Journal of Proteomics, April 27, 2018, Read More

Li, M., Reisman, J., Morris-Eppolito, B., Qian, S. X., Kazis, L. E., Wolozin, B., Goldstein, L. E., & Xia, W. Beneficial Association of Angiotensin-Converting Enzyme Inhibitors and Statins on the Occurrence of Possible Alzheimer’s Disease After Traumatic Brain Injury, Alzheimer's Research & Therapy, March 27, 2020, Read More